The 2022 Nanchang CACLP exhibition faced many obstacles due to the ongoing new crown epidemic. Despite the challenges and uncertainties, the 19th International Laboratory Medicine and Blood Transfusion Instruments and Reagents Expo was finally held on October 26-28, drawing in experts, scholars, entrepreneurs, manufacturers, distribution companies, investment banks, and laboratory medicine professionals from around the globe. CACLP is a prominent and highly influential exhibition event in the field of in vitro diagnostics, and its successful hosting at the Nanchang Greenland International Expo Center during this critical period is a testament to the organizers' diligence and resourcefulness. Despite the severe epidemic in the golden autumn season, the exhibition was held successfully, providing a vital platform for industry pros to come together and learn from each other.
Being a manufacturer that prides itself on creating intelligent products for thrombus and hemostasis diagnosis & POCT, we always ensure that our innovative solutions are at the forefront of our production process. Our products are designed to detect these conditions accurately and efficiently, making them ideal for use in hospitals and diagnostic centers. We are committed to using cutting-edge technology to provide the best possible results for our clients.
Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.At the CACLP event held in Nanchang, our company proudly showcased its comprehensive range of Mingmu® thromboelastography products and Lingmu® blood coagulation products, both automatic and POCT. This exhibition was a great opportunity for us to collaborate with various industries, fostering fruitful exchanges and knowledge sharing among friends and experts. We firmly believe that these interactions will contribute to the advancement of in vitro diagnostics and laboratory medicine.
Despite a significant decrease in professional visitors compared to previous years, the UD-Bio booth remains a hub of activity, attracting numerous professionals. The team at UD-Bio is dedicated to providing users with expert explanations and patiently communicating the unique product features and technical advantages. It is gratifying to see that many customers have recognized and appreciated the outstanding performance and innovative qualities of UD-Bio products. Despite the challenges, our booth continues to thrive with enthusiastic engagement from professionals seeking information and solutions.
UD-Bio recently showcased their latest product, the UD-T6000 series of magnetic levitation movable thromboelastography, during an exhibition. To complement this event, a professional academic satellite conference was organized at the Greenland Primus Hotel, aimed at bringing together experts in the field of critically ill blood coagulation. Professor Song Jingchun, who heads the Department of Critical Care Medicine at the 908th Hospital, was invited to deliver a lecture on his extensive experience using thromboelastography to monitor coagulation function in critically ill patients.
The lecture highlighted how thromboelastography has been instrumental in helping clinicians manage coagulation issues in critically ill individuals. Through his clinical experience, Professor Song demonstrated how this technology has been invaluable in deepening our understanding of the field of thrombosis, leading to better application of elastography in the management of severe coagulation. The professor also praised the potential of UD-Bio's magnetic levitation movable thrombelastogram device and commended the company for their contribution to advancements in the field.
Overall, the conference was an excellent opportunity to discuss the latest developments in the field of critically ill blood coagulation, and to exchange academic insights with fellow professionals. With the support of UD-Bio's innovative technology solutions like the UD-T6000 series, we can provide better treatment options for patients grappling with blood coagulation disorders.
